Delivery Order SPE2DB20D3104-SPE2DB22FV5T1
- Not listed
- This federal contract award is for the delivery of Premarin 0.3 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,020.20, is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which is valued at up to $999,999,999.00...
- This federal contract award is for the delivery of Premarin 0.625 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $15,456.50, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...
- This federal contract award is for the delivery of Premarin 0.3 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The $24,059.03 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,454.71, is for the delivery of 4,556,012,556 units of Premarin 0.625 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., doing business as Amerisourcebergen. This single-award IDC, valued at up to...
- This federal contract award is for the delivery of Premarin 0.45 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 12, 2022, with a ceiling value of $1,886.34. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
- This federal contract award is for the delivery of Premarin 0.625 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $28,204.38 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of August 23, 2023 and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Premarin 0.625 mg tablets. The contract, valued at $25,222.30, was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), on February 8, 2022, with a completion date of February 9, 2022. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award, valued at $1,122.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Premarin 0.625 mg tablets over a performance period ending on May 8, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Premarin 0.3 mg tablets. The contract, valued at $1,141.36, is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc. The IDC, worth up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products...
- This federal contract award is for the delivery of Premarin 0.625 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 26, 2023, with a ceiling value of $2,444.46 and a completion date of December 27, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB22FV5T1Delivery Order
This federal contract award is for the delivery of Premarin 0.625 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award has a ceiling value of $3,518.65 and does not have a set-aside designation, indicating open competition. This contract is part of Amerisourcebergen's broader role as a key supplier of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to various federal agencies, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 3/22/22 |